The $9 billion takeover of rail and port giant Asciano is set to get the greenlight from shareholders this week despite concerns from the competition watchdog, company chairman Malcolm Broomhead said.
Mr Broomhead, in Brisbane on Monday to give a personal donation to the University of Queensland, said approval of the bid would provide much needed capital to lift the capacity of Australia’s port and rail facilities.
Asciano has agreed to be taken over by a consortium including logistics firm Qube and Canadian infrastructure giant Brookfield.
However, the Australian Competition and Consumer Commission has delayed a decision on the deal saying it has received complaints the bid will reduce competition in the container logistics business. It is expected to announce its final decision by July 21.
Mr Broomhead said the takeover was likely to be given the greenlight at a shareholders meeting this Friday despite those concerns. “The ACCC issues are resolvable by the bidders,” he said. “They just have to find a way of doing it but I am sure they can.”
He said investment from foreign companies such as Brookfield was needed to build a competitive.
Full Content: Courirer Mail
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Orders Apple to Address Fortnite App Block or Face Court Hearing
May 19, 2025 by
CPI
EU Civil Society Groups and Labor Unions Raise Alarm Over Proposed Changes to GDPR
May 19, 2025 by
CPI
EU Antitrust Regulators Push Back Deadline on UniCredit’s Takeover Bid for Banco BPM
May 19, 2025 by
CPI
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas